Jim Simons Neogenomics Inc Transaction History

Renaissance Technologies LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$13.01 - $15.77 $1.64 Million - $1.99 Million	-126,300 Reduced 89.19%	15,300 $212,000
Q1 2024 May 13, 2024	BUY	$14.06 - $16.79 $587,708 - $701,822	41,800 Added 41.88%	141,600 $2.23 Million
Q4 2023 Feb 13, 2024	SELL	$11.67 - $20.73 $1.44 Million - $2.56 Million	-123,300 Reduced 55.27%	99,800 $1.62 Million
Q3 2023 Nov 14, 2023	BUY	$12.15 - $17.85 $2.71 Million - $3.98 Million	223,100 New	223,100 $2.74 Million
Q2 2022 Aug 12, 2022	SELL	$7.06 - $13.97 $1.74 Million - $3.44 Million	-246,000 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$12.15 - $35.28 $2.99 Million - $8.68 Million	246,000 New	246,000 $2.99 Million
Q4 2019 Feb 13, 2020	SELL	$18.96 - $29.84 $2.27 Million - $3.57 Million	-119,500 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$19.12 - $26.24 $2.28 Million - $3.14 Million	119,500 New	119,500 $2.29 Million
Q1 2019 May 14, 2019	SELL	$12.14 - $20.46 $4.89 Million - $8.24 Million	-402,700 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$11.24 - $18.5 $4.53 Million - $7.45 Million	402,700 New	402,700 $5.08 Million

295

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.06B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.